Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
Titel:
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
Auteur:
Traynor, Anne M. Hewitt, Maureen Liu, Glenn Flaherty, Keith T. Clark, Jason Freedman, Steven J. Scott, Boyd B. Leighton, Ann Marie Watson, Patricia A. Zhao, Baiteng O’Dwyer, Peter J. Wilding, George